Craft

Tenaya Therapeutics

Stock Price

$4.7

2024-05-03

Market Capitalization

$367.5 M

2024-05-03

Tenaya Therapeutics Summary

Company Summary

Overview
Tenaya Therapeutics is a biotechnology company that discovers, designs, develops, and delivers curative therapies that address heart diseases. It offers the Cellular Regeneration platform, the Gene Therapy platform, and the Precision Medicine platform dedicated to regenerate heart cells, restore cell function, reduce the scar area, and analyze human genetics.
Type
Public
Status
Active
Founded
2016
HQ
South San Francisco, CA, US | view all locations
Website
https://www.tenayatherapeutics.com/
Cybersecurity rating
Sectors

Key People

  • Faraz Ali

    Faraz Ali, Chief Executive Officer, Director

  • Leone Patterson

    Leone Patterson, Chief Financial and Business Officer

  • Jay Vora

    Jay Vora, Senior Vice President, Portfolio and Program Management

  • Matthew Pollman

    Matthew Pollman, Senior Vice President, Clinical Development

    LocationsView all

    1 location detected

    • South San Francisco, CA HQ

      United States

      171 Oyster Point Blvd., Suite 500

    Tenaya Therapeutics Financials

    Summary Financials

    Net income (Q1, 2024)
    ($32.2M)
    Cash (Q1, 2024)
    $59.3M
    EBIT (Q1, 2024)
    ($33.8M)

    Footer menu